Drug intelligence / Profile preview

Jindan Fuyan Granules

Development stage: Preclinical
Lead developer: Jiangxi Huatai Pharmaceutical
Administration: Oral

Overview

Jindan Fuyan Granules (金丹附延颗粒) is a Traditional Chinese Medicine (TCM) formulation manufactured by Jiangxi Huatai Pharmaceutical. It is typically prepared as granules for oral administration and is used to promote blood circulation and resolve blood stasis. In clinical research, it has been specifically investigated for its efficacy in treating lymphatic leakage following pelvic lymphadenectomy in patients with bladder cancer. The formulation is intended to facilitate the healing of lymphatic vessels and reduce post-operative complications by modulating microcirculation and inflammatory responses.

Brand names: Jindan
Other names: Jindan Fuyan KeliJindan With Extension Granules金丹附延颗粒

Beyond the preview

Go deeper on Jindan Fuyan Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jindan Fuyan Granules.

Explore the full profile